LMDXF — LumiraDx Share News
0.000.00%
Last trade - 00:00- $1.64m
- $378.94m
- $254.48m
Roche to buy part of LumiraDx diagnostics platform for $295 million
Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Brief: Willard L. Umphrey Reports 10.31% Stake In Lumiradx Limited As Of Dec 22- SEC Filing
LumiraDx Ltd expected to post a loss of 10 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Hasbro, Moderna, CymaBay
U.S. STOCKS ON THE MOVE-Alcoa, Harpoon, EngageSmart
Brief: Lumiradx Partners With Astrazeneca & Everton In The Community To Set Up England’S First Heart & Lung Screening Hub
On Aug 28, Unit Of Co Entered Into Tenth Amendment To Certain Loan Agreement, Dated March 23, 2021
U.S. STOCKS ON THE MOVE-Futu Holdings, Build-A-Bear Workshop, Copper miners
U.S. STOCKS ON THE MOVE-Medtronic, Futu Holdings, Align Tech
LumiraDX slips on bigger-than-expected loss
LumiraDx Ltd reports results for the quarter ended in June - Earnings Summary
LumiraDx Ltd expected to post a loss of 14 cents a share - Earnings Preview
LumiraDx Ltd expected to post a loss of 14 cents a share - Earnings Preview
Brief: LumiraDx's Point Of Care Diagnostics Group Continues Commercial Expansion Announcing Distribution Agreement With Axonlab
U.S. STOCKS ON THE MOVE-PureCycle, Amazon.com, Dollar Tree
U.S. STOCKS ON THE MOVE-PureCycle, Walt Disney, Chipotle Mexican Grill
U.S. STOCKS ON THE MOVE-Harley-Davidson, Eightco, Beauty Health